BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26412734)

  • 1. [Bone Cell Biology Assessed by Microscopic Approach. The effects of bisphosphonates on bone remodeling, microdamage accumulation and fracture repair process].
    Mashiba T
    Clin Calcium; 2015 Oct; 25(10):1537-40. PubMed ID: 26412734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone fracture and the healing mechanisms. The effects of anti-resorptive agents on fracture healing].
    Mashiba T; Mori S
    Clin Calcium; 2009 May; 19(5):673-9. PubMed ID: 19398835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Morphological analysis of bone dynamics and metabolic bone disease. Histological findings in animal fracture model--effects of osteoporosis treatment drugs on fracture healing process].
    Mashiba T
    Clin Calcium; 2011 Apr; 21(4):551-8. PubMed ID: 21447922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates: a case series.
    Armamento-Villareal R; Napoli N; Diemer K; Watkins M; Civitelli R; Teitelbaum S; Novack D
    Calcif Tissue Int; 2009 Jul; 85(1):37-44. PubMed ID: 19548019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.
    Yamagami Y; Mashiba T; Iwata K; Tanaka M; Nozaki K; Yamamoto T
    Bone; 2013 May; 54(1):1-7. PubMed ID: 23356990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [SSBT (severely suppressed bone turnover) ].
    Mori S
    Clin Calcium; 2013 Mar; 23(3):365-70. PubMed ID: 23445889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates: how do they work?
    Papapoulos SE
    Best Pract Res Clin Endocrinol Metab; 2008 Oct; 22(5):831-47. PubMed ID: 19028359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphological analysis of bone dynamics and metabolic bone disease. Does bisphosphonate treatment cause severely suppressed bone turnover (SSBT) ?].
    Kondo N; Yoda T
    Clin Calcium; 2011 Apr; 21(4):583-7. PubMed ID: 21447926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone remodeling during fracture repair: The cellular picture.
    Schindeler A; McDonald MM; Bokko P; Little DG
    Semin Cell Dev Biol; 2008 Oct; 19(5):459-66. PubMed ID: 18692584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is SSBT associated with atypical femoral fracture? SSBT is associated with atypical femoral fracture - pathophysiology of atypical femoral fractures - ].
    Mashiba T
    Clin Calcium; 2012 Jun; 22(6):914-8. PubMed ID: 22653033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A theoretical analysis of long-term bisphosphonate effects on trabecular bone volume and microdamage.
    Nyman JS; Yeh OC; Hazelwood SJ; Martin RB
    Bone; 2004 Jul; 35(1):296-305. PubMed ID: 15207770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [When should bisphosphonate treatment be discontinued?].
    Eriksen EF; Halse J
    Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1630-2. PubMed ID: 22875131
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib.
    Komatsubara S; Mori S; Mashiba T; Li J; Nonaka K; Kaji Y; Akiyama T; Miyamoto K; Cao Y; Kawanishi J; Norimatsu H
    J Bone Miner Res; 2004 Jun; 19(6):999-1005. PubMed ID: 15125797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate treatment delays stress fracture remodeling in the rat ulna.
    Kidd LJ; Cowling NR; Wu AC; Kelly WL; Forwood MR
    J Orthop Res; 2011 Dec; 29(12):1827-33. PubMed ID: 21598308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis.
    Simm PJ; Johannesen J; Briody J; McQuade M; Hsu B; Bridge C; Little DG; Cowell CT; Munns CF
    Bone; 2011 Nov; 49(5):939-43. PubMed ID: 21820091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive effects of PTH and bisphosphonates on the bone healing response to metaphyseal implants in rats.
    Aspenberg P; Wermelin K; Tengwall P; Fahlgren A
    Acta Orthop; 2008 Feb; 79(1):111-5. PubMed ID: 18283582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of osteoporosis medications on fracture healing.
    Hegde V; Jo JE; Andreopoulou P; Lane JM
    Osteoporos Int; 2016 Mar; 27(3):861-871. PubMed ID: 26419471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
    McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
    Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of antiresorptive therapy on the structural and material properties of bone strength].
    Kishimoto H
    Clin Calcium; 2016 Jan; 26(1):107-15. PubMed ID: 26728537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How do bisphosphonates affect fracture healing?
    Kates SL; Ackert-Bicknell CL
    Injury; 2016 Jan; 47 Suppl 1(0 1):S65-8. PubMed ID: 26768295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.